Home Cart 0 Sign in  

[ CAS No. 829-20-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 829-20-9
Chemical Structure| 829-20-9
Structure of 829-20-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 829-20-9 ]

Related Doc. of [ 829-20-9 ]

Alternatived Products of [ 829-20-9 ]

Product Details of [ 829-20-9 ]

CAS No. :829-20-9 MDL No. :MFCD00008727
Formula : C10H12O3 Boiling Point : -
Linear Structure Formula :- InChI Key :VQTDPCRSXHFMOL-UHFFFAOYSA-N
M.W : 180.20 Pubchem ID :70016
Synonyms :

Calculated chemistry of [ 829-20-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.62
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.05
Log Po/w (XLOGP3) : 1.86
Log Po/w (WLOGP) : 1.91
Log Po/w (MLOGP) : 1.13
Log Po/w (SILICOS-IT) : 2.19
Consensus Log Po/w : 1.83

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.27
Solubility : 0.962 mg/ml ; 0.00534 mol/l
Class : Soluble
Log S (Ali) : -2.23
Solubility : 1.07 mg/ml ; 0.00592 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.99
Solubility : 0.186 mg/ml ; 0.00103 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.46

Safety of [ 829-20-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 829-20-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 829-20-9 ]
  • Downstream synthetic route of [ 829-20-9 ]

[ 829-20-9 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 829-20-9 ]
  • [ 22395-22-8 ]
Reference: [1] Journal of the Chemical Society, 1918, vol. 113, p. 876
  • 2
  • [ 829-20-9 ]
  • [ 17720-60-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 17, p. 7917 - 7928
  • 3
  • [ 829-20-9 ]
  • [ 13330-65-9 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1963, p. 1003 - 1007
[2] Journal of Medicinal Chemistry, 1971, vol. 14, p. 1199 - 1202
[3] Journal of Heterocyclic Chemistry, 1984, vol. 21, # 4, p. 1141 - 1144
  • 4
  • [ 79-21-0 ]
  • [ 829-20-9 ]
  • [ 13330-65-9 ]
Reference: [1] Gazzetta Chimica Italiana, 1949, vol. 79, p. 924,927
  • 5
  • [ 79-21-0 ]
  • [ 104-15-4 ]
  • [ 64-19-7 ]
  • [ 829-20-9 ]
  • [ 13330-65-9 ]
Reference: [1] Gazzetta Chimica Italiana, 1949, vol. 79, p. 924,927
  • 6
  • [ 829-20-9 ]
  • [ 23504-03-2 ]
Reference: [1] Journal of the Chemical Society, 1951, p. 2019
  • 7
  • [ 829-20-9 ]
  • [ 6496-89-5 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 4, p. 540 - 546
[2] Journal of the Chemical Society, 1952, p. 4752,4755
[3] Bulletin de la Societe Chimique de France, 1954, p. 1397,1400
[4] Organic Preparations and Procedures International, 1992, vol. 24, # 6, p. 690 - 692
[5] Organic Process Research and Development, 2007, vol. 11, # 3, p. 414 - 421
  • 8
  • [ 4783-90-8 ]
  • [ 7051-13-0 ]
  • [ 6496-89-5 ]
  • [ 829-20-9 ]
Reference: [1] Tetrahedron, 1997, vol. 53, # 49, p. 16789 - 16794
  • 9
  • [ 829-20-9 ]
  • [ 59870-68-7 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 4, p. 540 - 546
[2] Synthetic Communications, 2014, vol. 44, # 4, p. 540 - 546
[3] Synthetic Communications, 2014, vol. 44, # 4, p. 540 - 546
[4] Synthetic Communications, 2014, vol. 44, # 4, p. 540 - 546
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 829-20-9 ]

Elvitegravir Intermediates

Chemical Structure| 151-10-0

[ 151-10-0 ]

1,3-Dimethoxybenzene

Chemical Structure| 924-99-2

[ 924-99-2 ]

Ethyl 3-(dimethylamino)acrylate

Chemical Structure| 6148-64-7

[ 6148-64-7 ]

Potassium 3-ethoxy-3-oxopropanoate

Chemical Structure| 2026-48-4

[ 2026-48-4 ]

(S)-2-Amino-3-methylbutan-1-ol

Chemical Structure| 28314-83-2

[ 28314-83-2 ]

5-Bromo-2,4-difluorobenzoic acid

Related Functional Groups of
[ 829-20-9 ]

Aryls

Chemical Structure| 1201-38-3

[ 1201-38-3 ]

1-(2,5-Dimethoxyphenyl)ethanone

Similarity: 0.98

Chemical Structure| 579-74-8

[ 579-74-8 ]

1-(2-Methoxyphenyl)ethanone

Similarity: 0.98

Chemical Structure| 131-57-7

[ 131-57-7 ]

(2-Hydroxy-4-methoxyphenyl)(phenyl)methanone

Similarity: 0.96

Chemical Structure| 39151-19-4

[ 39151-19-4 ]

1-(3,5-Dimethoxyphenyl)ethanone

Similarity: 0.95

Chemical Structure| 43113-94-6

[ 43113-94-6 ]

1-(3-Methoxy-5-methylphenyl)ethanone

Similarity: 0.93

Ethers

Chemical Structure| 1201-38-3

[ 1201-38-3 ]

1-(2,5-Dimethoxyphenyl)ethanone

Similarity: 0.98

Chemical Structure| 579-74-8

[ 579-74-8 ]

1-(2-Methoxyphenyl)ethanone

Similarity: 0.98

Chemical Structure| 131-57-7

[ 131-57-7 ]

(2-Hydroxy-4-methoxyphenyl)(phenyl)methanone

Similarity: 0.96

Chemical Structure| 39151-19-4

[ 39151-19-4 ]

1-(3,5-Dimethoxyphenyl)ethanone

Similarity: 0.95

Chemical Structure| 43113-94-6

[ 43113-94-6 ]

1-(3-Methoxy-5-methylphenyl)ethanone

Similarity: 0.93

Ketones

Chemical Structure| 1201-38-3

[ 1201-38-3 ]

1-(2,5-Dimethoxyphenyl)ethanone

Similarity: 0.98

Chemical Structure| 579-74-8

[ 579-74-8 ]

1-(2-Methoxyphenyl)ethanone

Similarity: 0.98

Chemical Structure| 131-57-7

[ 131-57-7 ]

(2-Hydroxy-4-methoxyphenyl)(phenyl)methanone

Similarity: 0.96

Chemical Structure| 39151-19-4

[ 39151-19-4 ]

1-(3,5-Dimethoxyphenyl)ethanone

Similarity: 0.95

Chemical Structure| 43113-94-6

[ 43113-94-6 ]

1-(3-Methoxy-5-methylphenyl)ethanone

Similarity: 0.93